Chronic Graft Versus Host Disease

general

A complication of allogeneic bone marrow or blood cell transplantation, usually occurring more than three months after transplantation, in which donor lymphoid cells damage the host tissue.

26

Centers

22

Active Trials

$302M

Cancer Funding

Specific Cancer Types(1)

Top Centers for Chronic Graft Versus Host Disease(26)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
74.6
273.2
3
NCI Comprehensive
Active Research Program
56.4
4
NCI Comprehensive
Active Research Program
56.4
5
NCI Comprehensive
Active Research Program
56.4
6
NCI Comprehensive
Active Research Program
56.4
7
NCI Comprehensive
Active Research Program
56.4
8
NCI Comprehensive
Active Research Program
56.4
9
NCI Comprehensive
Active Research Program
56.4
10
Active Research Program
56.4
11
NCI Comprehensive
Active Research Program
56.4
12
NCI Comprehensive
Active Research Program
56.4
13
Active Research Program
56.4
14
Active Research Program
56.4
15
NCI Comprehensive
Active Research Program
56.4
16
Active Research Program
56.4
1756.4
18
NCI Comprehensive
Active Research Program
53.5
19
NCI Comprehensive
Active Research Program
49.3
20
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
33.9
21
NCI Comprehensive
33.9
22
NCI Comprehensive
33.9
2333.9
2433.9
25
BC CancerVancouver, BC
33.9
26
NCI Comprehensive

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →